Indivior Pharmaceuticals annual operating expenses
2021
2022
2023
2024
2025
Indivior Pharmaceuticals Operating Expenses Growth & History (INDV)
Indivior Pharmaceuticals's operating expenses was $732.0M for fiscal 2025.
View full Indivior Pharmaceuticals company overviewIndivior Pharmaceuticals annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $732.0M | −$187.0M | −20.35% |
| 2024 | 2024-12-31 | $919.0M | −$153.0M | −14.27% |
| 2023 | 2023-12-31 | $1.07B | $241.0M | +29.00% |
| 2022 | 2022-12-31 | $831.0M | $380.0M | +84.26% |
| 2021 | 2021-12-31 | $451.0M | — | — |
Indivior Pharmaceuticals quarterly operating expenses
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $134.0M | −$45.0M | −25.14% |
| Q1 2026 | 2026-03-31 | $139.0M | −$17.0M | −10.90% |
| Q4 2025 | 2025-12-31 | $210.0M | $5.0M | +2.44% |
| Q3 2025 | 2025-09-30 | $187.0M | −$19.0M | −9.22% |
| Q2 2025 | 2025-06-30 | $179.0M | −$159.0M | −47.04% |
| Q1 2025 | 2025-03-31 | $156.0M | −$15.0M | −8.77% |
| Q4 2024 | 2024-12-31 | $205.0M | — | — |
| Q3 2024 | 2024-09-30 | $206.0M | — | — |
| Q2 2024 | 2024-06-30 | $338.0M | — | — |
| Q1 2024 | 2024-03-31 | $171.0M | — | — |
Indivior Pharmaceuticals operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, Indivior Pharmaceuticals's operating expenses increased from $451.0M to $732.0M, a change of $281.0M. The latest reported quarter, Q2 2026, shows $134.0M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Indivior Pharmaceuticals source filings ↗